Eurofins Medigenomix / MWG Biotech sequence Wacker Chemie AG's bacterial protein production strain
Eurofins Medigenomix GmbH / MWG Biotech AG have finalised a genome sequencing project with Wacker Chemie AG for the analysis of the genetic differences between Wacker's proprietary industrial protein production E. coli strain and its corresponding parental strain. The successful sequencing is an important step to further improve and advance Wacker's E.coli strain and the related proprietary E. coli secretion system, which is a well-established technology for cost-efficient production of proteins.
The genome of the E.coli strain was sequenced with ultra parallel shotgun sequencing using GS 20 technology, a high-throughput automated DNA sequencing system. The sequence reads have been assembled into contigs, i.e. sets of overlapping DNA segments, and subsequently analysed with MWG's proprietary genome comparison tool and displayed with the MWG's Annotation Viewer software.
"We are very impressed by the rapid and precise analysis of our E. coli production strain. The results will help us to further improve the performance of our production strain immensely", states Günter Wich, Head of the Biotechnology Department of Wacker Chemie AG's corporate R&D. "In addition, the further increase of efficiency will result in even more favourable cost of goods which we can offer to our customers. This is a key advantage over conventional protein production systems."
Wacker's E. coli secretion system is a commercialized and well-established technology for protein production. The core of the technology is Wacker's proprietary E. coli K12 strain, which is capable
of secreting a vast variety of different recombinant proteins in their native form into the fermentation broth during cultivation, according to the company.
Eurofins Medigenomix GmbH / MWG Biotech AG have finalised a genome sequencing project with Wacker Chemie AG for the analysis of the genetic differences between Wacker's proprietary industrial protein production E. coli strain and its corresponding parental strain. The successful sequencing ... more
With the new fully automated lab robot
RoboSeq 2500 DT Disposable Tips, MWG-Biotech announces the official
commercialization of the latest member of its successful series of
Automated Biosystems. The new system was officially launched on
Biotechnica in Hanover at the beginning of Octobe ... more
Pan® Oligo Sets is the brand name for MWG-Biotech’s new
oligonucleotide sets that enable customers to produce their own
oligonucleotide microarrays (DNA chips). The sets are based on the
competence and the success of MWG-Biotech’s Pan® Array series of
catalogue DNA chips and on the high ... more
MWG Biotech is an international provider of genomics products and services in DNA Oligonucleotide Synthesis, siRNA Synthesis, and DNA Sequencing. With strong customer orientientation, fast, web-based service and high quality products we provide the basis for success in the life sciences for ... more
Wacker Chemie AG opened a new production site for silicone elastomers in South Korea. The plant is located around 100 kilometers southeast of Seoul at Jincheon, where the Group has already been producing silicone sealants since 2010 and specialty silicones for the electronics industry since ... more
Wacker Metroark Chemicals Pvt. Ltd. is expanding its existing silicone production at its Amtala site near Kolkata with a new hydrosilylation plant for manufacturing functional silicone fluids. The plant with an annual capacity of over 6,000 metric tons was officially opened at a ceremony in ... more
As already reported, Wacker Chemie AG met or surpassed its own projections for all its performance indicators in 2017. On presenting its annual report, the Munich-based chemical company announced that Group sales reached €4.92 billion, up 6 percent year over year (2016: €4.63 billion). The ... more
WACKER is a globally operating chemical company headquartered in Munich, Germany. Its portfolio focuses on silicone chemistry, polymer chemistry, fine chemicals and biotech products, polysilicon, wafers and hyperpure silicon monocrystals. In line with these core areas of expertise, WACKER h ... more
Eurofins Scientific announces that it has opened a new food testing laboratory in Suzhou, China with a surface area of 3,900m2. This new laboratory, together with the laboratory opened in Qingdao last year, highlights Eurofins’ commitment to serving its clients in China and Asia Pacific wit ... more
Eurofins Scientific announces that it has successfully closed the transaction to acquire Protec Group’s water and food testing businesses in France (“Protec Bio-testing”). This acquisition comprises two laboratories with a total surface area over 1,500 m2.
One laboratory is mainly focused o ... more
Eurofins Scientific (EUFI.PA) announces that it has successfully closed the transaction to acquire Lab Frontier Co., Ltd., which provides a broad suite of food, environment and cosmetics testing services in South Korea. Lab Frontier, an affiliate company of Young In Group (YIG), will furthe ... more
Wacker is strengthening its biopharmaceutical operations in Jena, Germany. The Munich-based chemical Group is investing around EUR15 million in this undertaking, which involves the GMP expansion of its Jena production facility and the construction of a new building there for process develop ... more